PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1731612
PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1731612
The UK continuous glucose monitoring market, valued at $899.846 million in 2030 from $570.921 million in 2025, is projected to grow at a CAGR of 9.53%.
The medical device known as continuous glucose monitoring (CGM) provides ongoing blood sugar observation services to both type 1 and type 2 diabetes patients through wearable apparatus design. A substantial rise in CGM market demand exists across the UK due to numerous market factors.
The increasing number of diabetes patients and enhanced public understanding of CGM devices benefit the market due to government policies and financial support. The market continues to rise because of growing disposable income combined with healthcare having increased prominence in the industry. Other technological observation tools join the CGM device as essential elements that drive modern healthcare. These healthcare devices enable remote patients to use monitoring devices combined with wearable sensors through continuous glucose monitoring systems (CGMS).
Greater use of CGM devices: Adoption of CGM devices among people with diabetes in the UK is on the rise, fueled by heightened awareness of their effectiveness in improving blood glucose control. The National Health Service (NHS) has played a key role in expanding access to these devices, particularly for individuals with type 1 diabetes, often offering them at costs comparable to flash glucose monitors.
Why Purchase This Report?
Some of the major players covered in this report include Dexcom, Inc., Abbott Laboratories, and Medtronic plc among others.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence